The Dysfunctional Gangway: SZT2-associated Epilepsy with Thick Corpus Callosum

Mutations in seizure threshold 2 (SZT2) gene on chromosome 1p34.2 are an of late identified cause of epilepsy and epileptic encephalopathy. We report a 3-year-old girl who presented with developmental delay, dysmorphic facies, refractory seizures, and subsequent developmental regression. Despite significant multifocal epileptiform abnormalities on her electroencephalogram, she had a paucity of generalized discharges indicating a functional deficiency of corpus callosum inspite of its increased thickness seen on magnetic resonance imaging. Her clinical exome sequencing revealed a homozygous single base pair duplication in the SZT2 gene that resulted in a frameshift mutation and premature truncation of the protein. Our case emphasizes the role of SZT2 gene in the diagnostic algorithm of early childhood refractory epilepsy especially in the context of a thick yet dysfunctional corpus callosum.

[1]  N. Matsumoto,et al.  Constitutive activation of mTORC1 signaling induced by biallelic loss-of-function mutations in SZT2 underlies a discernible neurodevelopmental disease , 2019, PloS one.

[2]  Xuefei Zhong,et al.  Novel SZT2 mutations in three patients with developmental and epileptic encephalopathies , 2019, Molecular genetics & genomic medicine.

[3]  F. S. Domingues,et al.  Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly , 2019, Seizure.

[4]  A. Kariminejad,et al.  SZT2 mutation in a boy with intellectual disability, seizures and autistic features. , 2019, European journal of medical genetics.

[5]  Toshiyuki Yamamoto,et al.  Identification of a rare homozygous SZT2 variant due to uniparental disomy in a patient with a neurodevelopmental disorder. , 2018, Intractable & rare diseases research.

[6]  A. Gropman,et al.  Novel metabolic signatures of compound heterozygous Szt2 variants in a case of early‐onset of epileptic encephalopathy , 2018, Clinical case reports.

[7]  A. Vanderver,et al.  Mutations in SZT2 result in early‐onset epileptic encephalopathy and leukoencephalopathy , 2018, American journal of medical genetics. Part A.

[8]  M. Abu-Elmagd,et al.  A novel homozygous mutation in SZT2 gene in Saudi family with developmental delay, macrocephaly and epilepsy , 2018, Genes & Genomics.

[9]  S. Saitoh,et al.  Biallelic mutations in SZT2 cause a discernible clinical entity with epilepsy, developmental delay, macrocephaly and a dysmorphic corpus callosum , 2018, Brain and Development.

[10]  A. Takata,et al.  Novel biallelic SZT2 mutations in 3 cases of early‐onset epileptic encephalopathy , 2017, Clinical Genetics.

[11]  A. Vanderver,et al.  Whole exome sequencing in patients with white matter abnormalities , 2016, Annals of neurology.

[12]  J. Millichap,et al.  Early-life epileptic encephalopathy secondary to SZT2 pathogenic recessive variants. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[13]  M. Tekin,et al.  An Amino Acid Deletion in SZT2 in a Family with Non-Syndromic Intellectual Disability , 2013, PloS one.

[14]  Dvir Dahary,et al.  Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum. , 2013, American journal of human genetics.

[15]  C. Mahaffey,et al.  Szt2, a novel gene for seizure threshold in mice , 2009, Genes, brain, and behavior.